MMedication Read More People with MS in England to be given fampridine as patent expiresJuly 29, 2026 Adults with multiple sclerosis (MS) and associated walking impairment in England are now eligible for NHS treatment with…
MMedication Read More Pharmacist issues ‘arrest’ warning for anyone taking common meds abroadJuly 29, 2026 Drugs issued by prescription, and even some bought over the counter in the UK, are banned abroad Neil…
MMedication Read More Simtriyo (Centanafadine) for ADHD: How It Works and Side EffectsJuly 29, 2026 People with ADHD who don’t do well or see enough symptom improvement with existing drugs have a new…
MMedication Read More Doctors share warning about how impact extreme summer heat can interact with everyday medicationsJuly 28, 2026 As temperatures continue to rise across Georgia, doctors and pharmacists are issuing a reminder about mixing medicine with…
MMedication Read More Mental Health Effects of GLP-1 MedicationsJuly 28, 2026 Glucagon-like peptide-1 (GLP-1) is a hormone that helps regulate blood glucose levels, slow digestion, and promote a sense…
MMedication Read More FDA Approves Fast-Acting Acetaminophen-Naproxen Combo for Pain ReliefJuly 28, 2026 Share on PinterestA new fast-acting pain relief medication contains the active ingredients acetaminophen (Tylenol) and naproxen (Aleve). Photo…
MMedication Read More Popular Antihistamine Tablets Recalled Due to Potential Cross-Contamination That May Be Life-Threatening: FDAJuly 28, 2026 NEED TO KNOW Unique Pharmaceuticals recalled four lots of cetirizine hydrochloride tablets due to potential contamination with ranitidine…
MMedication Read More FDA approves Tylenol with Naproxen OTC comboJuly 28, 2026 (Gray News) – The first fixed-dose combination of acetaminophen (Tylenol) and naproxen sodium was approved by the FDA.…
MMedication Read More FDA approves Tylenol with Naproxen OTC comboJuly 28, 2026 (Gray News) – The first fixed-dose combination of acetaminophen (Tylenol) and naproxen sodium was approved by the FDA.…
MMedication Read More Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical studyJuly 28, 2026 Adult B-ALL exhibits significant heterogeneity and poor prognosis compared with the pediatric population. While the complete remission (CR)…
MMedication Read More FDA Approves Mannkind’s At-Home Treatment Option for Heart Failure or Kidney DiseaseJuly 28, 2026 Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Mannkind…
MMedication Read More Supply fears over life-saving blood pressure medication taken by millions of BritonsJuly 28, 2026 Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…